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Abstract
Background: The no-reflow phenomenon due to microvasculature damage is sometimes
observed in patients despite patency of the infarct-related artery. The study aimed to assess the
predictive value of clinical, hemodynamic and electrocardiographic parameters for the develop-
ment of the no-reflow phenomenon in patients after successful coronary reperfusion.
Methods: Eighty-six patients, mean age 58.4 ± 11.2, underwent primary percutaneous
coronary intervention (PCI) for acute anterior myocardial infarction (AMI). Angiographic param-
eters, i.e. TIMI grade flow, cTFC, TMPG, wall motion score index (WMSI), ST-segment resolu-
tion and segmental perfusion, were estimated by myocardial contrast echocardiography (MCE).
Results: As evidenced by MCE, 54 patients were classified as the reflow ones and 32 as no-
-reflow. Patients from the no-reflow group showed a higher creatine kinase peak (p = 0.0034),
higher kinase-MB (p = 0.0033) and higher troponin level (p = 0.062), longer time span
between the onset of pain and reperfusion (p = 0.0003), worse baseline WMSI (p = 0.0022),
inferior flow in the infarct-related artery and ST-segment resolution. Univariate analysis
revealed that age, time span between the onset of chest pain to PCI, all angiographic param-
eters, WMSI and ST-segment resolution were related to the no-reflow phenomenon.
Multivariate logistic regression analysis revealed that lack of preservation of normal or near-
normal flow before PCI and significant impairment of left ventricle contractility were inde-
pendent predictive factors of the no-reflow phenomenon.
Conclusions: MCE yields vital information about the outcome of coronary intervention in
patients with AMI. Development of a no-reflow phenomenon is correlated with the severity of
myocardial damage and poor flow through the infarct-related artery before PCI. (Cardiol J
2008; 15: 57–62)
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Editorial p. 1 Introduction
The treatment of patients with acute myocar-
dial infarction (AMI) is aimed at the restoration of
patency in the infarct-related artery. Successful
coronary recanalisation is not always associated,
however, with the actual restoration of myocardial
perfusion. In about one third of patients with acute
myocardial infarction, no adequate perfusion was ob-
served, due to microvascular damage sustained [1, 2].
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In these patients, left ventricle remodelling, cardiac
events and poor follow-up outcome occurred more
frequently. Regretfully, clinical assessment does
not facilitate accurate identification of reperfusion [3].
Myocardial contrast echocardiography (MCE)
has recently emerged as a potentially useful meth-
od of studying myocardial perfusion in coronary
artery disease and reperfusion after acute myocar-
dial infarction. Experimental studies in animals have
confirmed that MCE accurately delineates myocar-
dium during coronary occlusion, as well as the ulti-
mate size of an infarct [4–7].
Several factors are reported to impact microv-
ascular damage, clinical condition and ultimate out-
come of patients with AMI, although their contri-
bution in the development of the no-reflow phenom-
enon as yet remains undetermined [8].
The present study aimed to compare clinical,
hemodynamic and electrocardiographic parameters
in patients characterised by reflow and those fea-
turing no-reflow phenomenon, after a reperfused
anterior wall AMI, with a view to establishing their
predictive value in relation to the no-reflow phe-
nomenon.
Methods
Eighty-six patients, 68 men and 18 women
(mean age 58.4 ± 11.2 years; range 29–78), under-
went coronary angioplasty (PCI, percutaneous cor-
onary intervention) following diagnosis of anterior
wall acute myocardial infarction, within 12 hours of
the onset of symptoms. The diagnosis was made on
the basis of prolonged chest pain ≥ 30 min, ST-seg-
ment elevation ≥ 2 mm in two contiguous electro-
cardiographic leads and an increase in serum cre-
atinine kinase, or troponin levels. Hemodynamically
unstable patients were excluded from the study.
Two-dimensional echocardiography and MCE
was performed in all patients before and immedi-
ately after PCI. Two-dimensional images of the
parasternal long and short-axis view and apical long
axis 4- and 2-chamber view were obtained using the
Aloka™ system and an ultrasound harmonic transduc-
er transmitting 1.88 MHz and receiving 3.75 MHz.
The dynamic range was approximately 60 dB. Wall
motion (WM) was interpreted in line with the es-
tablished criteria. Regions were scored as normal
or abnormal: hypokinetic, akinetic or dyskinetic, in
compliance with the American Society of Echocar-
diography guidelines [9]. Wall motion score index
(WMSI) was calculated as the sum of individual
scores of the respective segments divided by the
actual number of segments.
Myocardial perfusion was assessed in real time,
using Optison™ second generation contrast agent
which was injected as a bolus (0.3–0.5 ml) at a low
mechanical index (0.3), through harmonic imaging,
and with a 16-segment model of the left ventricle.
Segmental myocardial contrast was graded semi-
quantitatively in line with the following score: 0 —
lack of perfusion (no visible contrast effect), 0.5 —
partial perfusion (patchy myocardial contrast en-
hancement), 1 — normal perfusion (homogenous
contrast effect). The risk area was defined as the
number of segments with no perfusion prior to an-
gioplasty.
We defined the no-reflow zone on the end-
-diastolic images as a contrast perfusion defect
after PCI. We quantified the area of no-reflow as its
ratio to the risk area — lack of perfusion before PCI.
When the ratio exceeded 25%, myocardial reper-
fusion in the corresponding segments was consid-
ered incomplete (MCE no-reflow). If this ratio was
£ 25%, we regarded myocardial reperfusion as ad-
equate (MCE reflow).
ST-segment resolution was analysed in all pa-
tients. The sum of ST elevation was assessed in
three contiguous leads in the infarct zone, 60 ms
from the J point. The extent of ST-segment resolu-
tion was assessed 90 and 180 minutes after reper-
fusion and expressed as the percentage of the
ST-segment elevation shown on the baseline pre-
senting ECG [10].
Coronary angiography was performed in mul-
tiple projections, using the standard Judkins tech-
nique. The patency of the infarct-related artery was
classified in compliance with the thrombolysis in
myocardial infarction (TIMI) criteria; whereas the
corrected TIMI frame count (cTFC) and TIMI
Myocardial Perfusion Grade (TMPG) were as-
sessed using the techniques described in detail in
previous reports [11–13].
Primary PCI was performed in all patients.
Twenty-two patients, whose estimated transfer
time was in excess of 90 minutes, were adminis-
tered with a reduced dose of a fibrinolytic drug —
alteplase (bolus of 15 mg, followed by an infusion
of 35 mg/60 min) and glycoprotein IIb/IIIa inhibitor
— abciximab (bolus of 0.25 mg/kg followed by an
infusion of 0.125 mg/kg/min, max. 10) before the
actual transportation to our cat-lab. These infusions
were continued during the actual transfer to the cat-
lab, with a view to performing coronary angioplasty,
hence named the facilitated angioplasty.
The study protocol was approved by the local
ethical committee and informed consent was ob-
tained from each patient.
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Statistical analysis
Continuous data were expressed as mean ±
± SD standard deviation and were compared using
Student’s t-test. We made comparisons by using
one-way analysis of variance for continuous varia-
ble, and the significance of the difference was cal-
culated by using the Scheffé F-test for factor anal-
ysis. Categorical variables were compared by us-
ing the chi-square test or Fisher’s test. Univariate
and multivariate logistic regression analyses were
used to identify independent predictors for devel-
opment of the no-reflow phenomenon. Differences
were considered significant at p < 0.05.
Results
Out of 86 study subjects, 68 (79%) had no his-
tory of coronary artery disease or pre-infarction
angina, 18 (21%) had previously experienced chest
pains, 52 (60%) had suffered from hypertension,
66 (77%) from hyperlipidemia, 22 (26%) from diabe-
tes mellitus, and 38 (44%) had a history of smoking.
Significant stenosis of the left anterior descend-
ing (LAD) coronary artery in the 6th or 7th segment
(mean 92.3 ± 12.6%) was confirmed in all patients.
Forty-five patients had single-vessel and 23 had
double-vessel disease with a non-significant coro-
nary stenosis (< 50% luminal diameter stenosis)
in the second coronary artery, whereas in 18 pa-
tients significant coronary stenosis (50–70% lumi-
nal diameter stenosis) was observed in other arter-
ies than the infarct-related one.
Total occlusion of the infarct-related coronary
artery (TIMI 0) was observed in 34 patients, and in
38 patients (mainly from the facilitated angioplasty
group) coronary flow appeared (TIMI 2 or 3).
Using MCE, the no-reflow phenomenon was
observed within the risk area in 32 patients (37%)
(MCE no-reflow), and the remaining 54 (63%) of
patients were classified as the reflow ones (MCE
reflow). Table 1 shows the characteristics of the
total of patients as well as both groups of patients:
with MCE reflow and with MCE no-reflow.
The patients with MCE no-reflow were char-
acterised by longer time elapsed from the onset of
chest pain to coronary angioplasty (p = 0.0003),
higher level of creatine kinase peak (CPK) (p =
= 0.0034) and CPK/MB (p = 0.0033) and troponin
(p = 0.062), smaller flow in epicardial artery, as de-
termined by TIMI and cTFC, and smaller myocar-
dial perfusion, as determined by TMPG before PCI.
Among 34 patients with complete occlusion
(TIMI flow grade 0) of the LAD, higher incidence
of TIMI flow grade 0 was observed before PCI in
patients with MCE no-reflow than in patients with
MCE-reflow, i.e. 23 vs. 11 patients, respectively
(p = 0.0026). After PCI, TIMI 0 or 1 was observed
only in patients with MCE no-reflow. Among 36 pa-
tients with TMPG 0 before PCI, 28 patients were
classified to the MCE no-reflow group. After PCI,
TMPG 0 was observed only in patients with MCE
no-reflow (p = 0.0001).
WMSI was greater and ST-segment resolution
was smaller in patients with MCE no-reflow than
in those with MCE reflow. In 21 patients with MCE
no-reflow, ST-segment resolution was < 30%,
whereas this value was noted only in one patient
within the MCE reflow group. Complete resolution
(ST-segment resolution > 70%) was observed only
in patients in the MCE reflow group (Table 1).
We did not find any differences between the
respective groups of patients treated with either
primary or facilitated angioplasty. As evidenced by
MCE in 39 (61%) patients treated with primary PCI
and 15 (68%) treated with the facilitated one, there
was a significant improvement of myocardial per-
fusion after PCI — reflow group (p = 0.461).
Multivariate logistic regression analysis re-
vealed that lack of preservation of normal or near-
normal flow before PCI (OR = 2.6455; p = 0.0663)
and significant impairment of left ventricle contrac-
tility (OR = 0.0001; p = 0.0303) were independent
predictive factors of the no-reflow phenomenon.
Univariate analysis indicated that age, time
elapsed from the onset of chest pain to coronary
angioplasty, complete occlusion (TIMI 0) or poor
flow in the LAD, as assessed by cTFC, poor myo-
cardial perfusion, as assessed by TMPG, and poor
ST-segment resolution, were independent predic-
tors of the no-reflow phenomenon (Table 2).
Discussion
Microvascular damage due to AMI remains an
important prognostic factor. In about one third of
patients with AMI, despite angiographically estab-
lished patency of the infarct-related artery, there
was no adequate perfusion, due to microvascular
damage sustained. The patients with no improve-
ment of myocardial perfusion after successful PCI
made up the high-risk group, hence having rather
poor follow-up outcome, and a lack of recovery of
left ventricular function might reasonably be antici-
pated [14, 15].
In the present study we investigated the fac-
tors related to the no-reflow phenomenon in pa-
tients with anterior wall acute myocardial infarction.
Much in keeping with the reports of other investi-
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Table 1. Characteristics of patients with myocardial contrast echocardiography (MCE) reflow and MCE
no-reflow immediately after coronary angioplasty.
Total MCE reflow MCE no-reflow p
(n = 86) (n = 54) (n = 32)
Age (years) 58.4 ± 11.2 55.7 ± 11.9 63.04 ± 9.7 0.0114
Women/men 18/68 11/43 7/25 0.5758
Time to PCI 3.9 ±1.3 3.1±1.25 4.7±1.4 0.003
Peak creatine kinase [U/L] 3973.32±3887.6 2940.4±3298.4 5694.7±4253.1 0.0034
Peak creatine kinase-MB [U/L] 388.16±343.4 306.5±335.1 524.1±319.9 0.0033
Troponin 57.5±85.7 37.9±74.1 87.2±94.9 0.0629
Diameter stenosis before PCI (%) 92.3±12.6 90.1±13.8 95.9±9.0 0.0032
TIMI before PCI
TIMI 0 34 (39%) 11 (20%) 23 (72%) 0.0026
TIMI 1 14 (16%) 8 (15%) 6 (19%) 0.6864
TIMI 2 23 (27%) 21 (39%) 2 (6%) 0.0087
TIMI 3 15 (18%) 14 (26%) 1 (3%) 0.02
TIMI after PCI
TIMI 0 1 (1%) 0 1 (3%) 0.1982
TIMI 1 5 (6%) 0 5 (16%) 0.0055
TIMI 2 16 (19%) 5 (9%) 11 (34%) 0.019
TIMI 3 64 (74%) 49 (91%) 15 (47%) 0.0721
cTFC before PCI 62.45±39.1 42.2±23.4 92.2±38.9 0.00009
cTFC after PCI 39.3±31.1 27.1±14.3 57.3±40.8 0.0028
TMPG before PCI
TMPG 0 36 (42%) 8 (15%) 28 (88%) 0.001
TMPG 1 9 (10%) 8 (15%) 1 (3%) 0.1177
TMPG 2 25 (29%) 22 (40%) 3 (9%) 0.017
TMPG 3 16 (19%) 16 (30%) 0 0.0032
TMPG after PCI
TMPG 0 11 (13%) 0 11 (34%) 0.0001
TMPG 1 14 (16%) 0 14 (44%) < 0.0001
TMPG 2 25 (29%) 19 (35%) 6 (19%) 0.2205
TMPG 3 36 (42%) 35 (65%) 1 (3%) 0.0001
ST-segment resolution < 30% 22 (26%) 1 (2%) 21 (66%) < 0.0001
ST-segment resolution 30–70% 30 (35%) 19 (35%) 11 (34%) 0.9577
ST-segment resolution > 70% 34 (39%) 34 (63%) 0 < 0.0001
Pre-infarction angina 18 (21%) 11 (20%) 7 (22%) 0.8935
No pre-infarction angina 68 (79%) 43 (80%) 25 (78%) 0.9548
Diabetes mellitus 22 (26%) 12 (22%) 10 (31%) 0.4790
Hypertension 52 (60%) 29 (54%) 23 (72%) 0.4143
Hyperlipidemia 66 (77%) 44 (81%) 22 (69%) 0.6207
Smoking 38 (44%) 14 (26%) 24 (75%) 0.0074
Family history of CAD 31 (36%) 21 (39%) 10 (31%) 0.6222
WMSI before PCI 1.6±0.17 1.55±0.18 1.7±0.1 0.0022
WMSI after PCI 1.48±0.22 1.37±0.18 1.66±0.15 0.00004
WMSI 3 day 1.36±0.21 1.25±0.18 1.55±0.12 0.00009
EF before PCI (%) 43.5±9.7 47.9±7.4 36.8±8.9 0.001
EF after PCI (%) 44.1±9.5 48.4±7.3 37.6±9.1 0.001
EF 3 day (%) 49.8±8.9 54.2±7.1 42.8±6.8 0.001
CAD — coronary artery disease; TIMI — thrombolysis in myocardial infarction trial flow grade; cTFC — corrected TIMI frame count;
TMPG — TIMI myocardial perfusion grade; PCI — percutaneous coronary intervention; WMSI — wall motion score index; EF — ejection fraction
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gators, univariate analysis indicated that the age of
patients, segmental left ventricular function (as
assessed by WMSI) and the initial flow through the
infarct-related artery were the factors actually in-
strumental in the development of a no-reflow phe-
nomenon [16, 17].
Several studies pointed to the protective role
of residual coronary flow, which also happens to be
very much in line with our own findings. Patients
with totally occluded coronary arteries tended to
have poor final TIMI flow compared to those with
partially occluded vessels [18–21]. Complete occlu-
sion of the infarct-related artery (TIMI 0), poor flow
of LAD (as assessed by cTFC) and poor myocardial
perfusion (as assessed by TMPG) visibly affected
the actual development of the no-reflow phenomenon.
Seventy two per cent of patients characterised by in-
itial TIMI 0 and 88% of patients with TMPG 0 were
therefore allocated to the MCE no-reflow group.
Combination fibrinolytic therapy restored inf-
arct-related artery potency in 18 (81%) patients of
the facilitated angioplasty group before PCI but did
not effect clinical outcomes.
Our study indicated that the severity of myo-
cardial damage before coronary reperfusion impact-
ed the final results [22–26]. All parameters which
attested to myocardial damage, i.e. longer time to
reperfusion, higher level of myocardial necrotic fac-
tors, smaller ST-segment resolution, were closely
related to the no-reflow phenomenon.
Some authors have argued that pre-infarction
angina might actually attenuate the development of
the no-reflow phenomenon [27, 28]. However, our
study found no evidence to support this assertion.
Neither did we observe any differences between
patients with or without pre-infarction angina in
either group, nor indeed any impact on the actual
development of the no-reflow phenomenon.
From several clinical risk factors, only hyper-
lipidemia and smoking habit prove to be significant
predictors of the no-reflow phenomenon [29].
Conclusions
1. Myocardial contrast echocardiography yields
useful information on the outcome of coronary
intervention in patients with anterior wall acute
myocardial infarction.
2. Development of the no-reflow phenomenon fre-
quently appears to be correlated with the severi-
ty of myocardial damage (higher level of myocar-
dial necrotic markers, longer duration of ischemia).
3. Preservation of normal or near-normal coro-
nary flow before intervention correlates signif-
icantly with good PCI outcome in patients with
anterior wall acute myocardial infarction.
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